We are live on
!
Find out more
NanoViricides
NNVC
NNVC
26 hedge funds and large institutions have $3.74M invested in NanoViricides in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
925% more capital invested
Capital invested by funds: $365K → $3.74M (+$3.37M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
24% more funds holding
Funds holding: 21 → 26 (+5)
4.99% more ownership
Funds ownership: 3.8% → 8.79% (+5%)
Holders
26
Holders Change
+5
Holders Change %
+23.81%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
4
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.27M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$446K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$353K |
| 4 |
Morgan Stanley
New York
|
+$320K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$283K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$220K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$15.2K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6.79K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| 5 |
JP Morgan Chase
New York
|
-$1K |
